Image 1 (IMAGE)

The University of Hong Kong

Image 1

Caption

With a generous donation from the Li Ka Shing Foundation, HKUMed will be the first institution in Asia to introduce the groundbreaking Histotripsy system, using state-of-the-art histotripsy technology for clinical trials, offering Hong Kong liver cancer patients access to non-invasive, painless and highly effective treatment. Mr Li Ka Shing (right) is excited to witness this transformative technology that can kill cancer with bubbles. (From second right) Professor Albert Chan Chi-yan, HKUMed; Professor Chak-sing Lau, Dean of Medicine, HKU; Dr Theresa Li, Cluster Chief Executive, Hong Kong West Cluster; and Dr Vince Lau, HKUMed.

Credit

The University of Hong Kong

Usage Restrictions

N/A

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.